RICHARD G PESTELL
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD429307
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19123
Personal information
See more information about RICHARD G PESTELL at radaris.comName
Address
Phone
403 S 3Rd St, Philadelphia, PA 19147
403 3Rd St, Philadelphia, PA 19147
Professional information
See more information about RICHARD G PESTELL at trustoria.com
Richard Pestell, Philadelphia PA
Richard Pestell, Philadelphia PA
Work:
Thomas Jefferson University Hospital
233 S 10Th St, Philadelphia, PA 19107
233 S 10Th St, Philadelphia, PA 19107
Dr. Richard G Pestell, Philadelphia PA - MD (Doctor of Medicine)
Dr. Richard G Pestell, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Oncology
Address:
Richard G. Pestell, MD
111 S 11Th St SUITE G4240, Philadelphia 19107
(215) 503-5692 (Phone)
111 S 11Th St SUITE G4240, Philadelphia 19107
(215) 503-5692 (Phone)
Languages:
English
Hospitals:
Richard G. Pestell, MD
111 S 11Th St SUITE G4240, Philadelphia 19107
Jefferson University Hospitals - City Center
111 South 11Th St, Philadelphia 19107
111 S 11Th St SUITE G4240, Philadelphia 19107
Jefferson University Hospitals - City Center
111 South 11Th St, Philadelphia 19107
Professor And Director At Thomas Jefferson University
Professor And Director At Thomas Jefferson University
Location:
Greater Philadelphia Area
Industry:
Hospital & Health Care
Director At Kimmel & Associates
Director At Kimmel & Associates
Location:
Greater Philadelphia Area
Industry:
Hospital & Health Care
Richard G Pestell, Philadelphia PA
Richard G Pestell, Philadelphia PA
Specialties:
Oncologist
Address:
615 Chestnut St, Philadelphia, PA 19106
Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
US Patent:
2012019, Jul 26, 2012
Filed:
Feb 18, 2010
Appl. No.:
13/202312
Inventors:
Michael P. Lisanti - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
International Classification:
C40B 30/04, C40B 40/10, G01N 21/64, G01N 33/566, C12Q 1/68
US Classification:
506 9, 435 71, 435 612, 435 792, 506 18
Abstract:
The invention provides diagnostic and therapeutic methods for neoplastic disease patients with neoplasms of, for example, the breast, skin, kidney, lung, pancreas, rectum and colon, prostate, bladder, epithelial, non-epithelial, lymphomas, sarcomas, melanomas, and the like, wherein the method comprises determining the level of expression o caveolin-1, caveolin-2, vimentin, calponin2, tropomyosin, gelsolin, prolyl 4-hydroxylase alpha, EF-I-delta, or M2-isoform of pyruvate kinase in stromal cells adjacent to the neoplasm.
Use Of Modulators Of Ccr5 In The Treatment Of Cancer And Cancer Metastasis
Use Of Modulators Of Ccr5 In The Treatment Of Cancer And Cancer Metastasis
US Patent:
2013030, Nov 14, 2013
Filed:
May 14, 2013
Appl. No.:
13/893791
Inventors:
Richard G. PESTELL - Philadelphia PA, US
International Classification:
G01N 33/50, A61K 31/506, A61K 31/46
US Classification:
51421018, 435 723, 514304, 51425218, 514394, 5142305, 5142242
Abstract:
This disclosure is directed, in part, to a method of determining whether a subject having cancer is at risk for developing metastasis of the cancer. In one embodiment, the method comprises (a) obtaining a biological sample from the subject having cancer; (b) determining CCR5 expression level and/or expression level of at least one of CCR5 ligands in the biological sample; and (c) if the expression level of CCR5 and/or of at least one of CCR5 ligands determined in step (b) is increased compared to CCR5 expression level and/or expression level of at least one of CCR5 ligands in a control sample, then the subject is identified as likely at risk for developing metastasis of the cancer.
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
US Patent:
2012003, Feb 16, 2012
Filed:
Feb 19, 2010
Appl. No.:
13/202318
Inventors:
Michael P. Lisanti - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
International Classification:
A61K 49/00, G01N 33/566, G01N 33/577, C12Q 1/02, A61K 38/17, A61K 39/395, A61K 38/18, A61K 38/21, A61K 31/565, A61K 31/5377, A61K 31/69, A61K 33/24, A61K 38/13, A61K 31/444, A61K 31/553, A61K 31/7004, A61P 35/00, C40B 30/00
US Classification:
424 91, 506 7, 435 723, 435 71, 435 29, 514 133, 4241331, 4241581, 514 77, 424 857, 514182, 5142345, 514 64, 424649, 514 199, 514332, 51421108, 514 23
Abstract:
The invention provides diagnostic and therapeutic methods for neoplastic disease patients with neoplasms of for example, the breast, skin, kidney, lung, pancreas, rectum and colon, prostate, bladder, epithelial, non-epithelial; lymphomas, sarcomas, melanomas, and the like, comprising determining the level of caveolin-1 and/or caveolin-2 in stromal cells adjacent to a neoplasm.
Methods And Compositions For The Diagnosis, Prognosis, And Treatment Of Cancer
Methods And Compositions For The Diagnosis, Prognosis, And Treatment Of Cancer
US Patent:
2013001, Jan 10, 2013
Filed:
Jan 6, 2011
Appl. No.:
13/520759
Inventors:
Richard G. Pestell - Philadelphia PA, US
Kongming Wu - Wynnewood PA, US
Xuanmao Jiao - Rockville MD, US
Sanjay Katiyar - Vienna VA, US
Vladimir M. Popov - Philadelphia PA, US
Mathew Casimiro - Cherry Hill NJ, US
Kongming Wu - Wynnewood PA, US
Xuanmao Jiao - Rockville MD, US
Sanjay Katiyar - Vienna VA, US
Vladimir M. Popov - Philadelphia PA, US
Mathew Casimiro - Cherry Hill NJ, US
International Classification:
A61K 31/706, A61P 35/00, A61K 48/00, A61K 38/02, A61K 31/7068, A61K 39/395
US Classification:
4241581, 514 42, 514 49, 514 44 R, 514 193
Abstract:
Methods and compositions for diagnosing and treating cancer, such as breast cancer are provided. In particular, methods and compositions relating to nucleic acids encoding DACH1 and DACH1 proteins are provided.